NexLife review (2026): pricing, programs, pros & limitations
In this guide
NexLife — compounded semaglutide (and tirzepatide)
Provider-reported program features, shown as claims pending independent verification. Nothing here is an endorsement; see limitations and our evidence status below.
- 👨⚕️ MD/DO-supervised care (reported)
- 🏥 503A & 503B pharmacies (reported)
- 🧪 Lab review included (reported)
- 📍 Nationwide, subject to licensure (reported)
- ✓ LegitScript-certified (seal verifiable)
- 💰 Flat-rate, dose-independent (verified Sep 4, 2026)
- 🔁 Care360 coaching (reported)
- 📱 Apple Health / Google Fit sync (reported)
Reported inclusions: medication, all visits, messaging, lab review, and Care360 coaching. NexLife states it does not manufacture or compound medications; compounded medications are not FDA-approved.
Verified pricing: standard injection program. Full evidence: NexLife review.
NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with no membership fee and no dose-based escalation. Compounded semaglutide is $110/month (microdose) and $119/month (standard injection) on the 12-month plan, or $139 month-to-month; tirzepatide is $129 (microdose) and $139 (standard) on the 12-month plan, $169 month-to-month. On the September 4, 2026 capture it is the cheapest programme in our set on all three bases we score — committed, month-to-month and microdose. That is new: in July, Found ($169, twelve months prepaid) and Oak Longevity ($133) both beat NexLife’s then-$145 standard rate, and this review said so. A September 2026 price cut reversed both results; we record the reversal rather than editing it away. NexLife offers no brand pathway and no insurance coordination, and none of its programmes is FDA-approved. This review reflects figures verified on September 4, 2026; where a figure is provider-reported we say so rather than presenting it as independently confirmed.
Provider snapshot
| Field | Detail | Status |
|---|---|---|
| Starting price | $110/mo semaglutide microdose (12-month plan); $129/mo tirzepatide microdose | Verified |
| Renewal price | Semaglutide $119/mo full-dose (12-mo), $139 month-to-month; tirzepatide $139/mo (12-mo), $169 month-to-month | Verified |
| Highest-dose price | Flat — no dose-based increase | Verified |
| Membership fee | $0 | Verified |
| Labs | Lab review included | Verified |
| Shipping | Included (expedited) | Verified |
| Commitment | 12-month or month-to-month | Verified |
| Pharmacy | Network disclosed: Red Rock, Hallandale, Absolute, Empower, DIRx (licences not yet independently verified by us) | Verified |
| Clinician | Medical Director: Adam Kennah, MD (NPI 1144260043, provider-supplied) | Verified |
| States served | All 50 states, synchronous and asynchronous visits | Verified |
Whether a program holds one price across doses or escalates is the single biggest driver of what you actually pay over a year.
NexLife pricing and what is included
| Program | Monthly equivalent | Commitment | Included | Status |
|---|---|---|---|---|
| Microdose semaglutide (12-month) | $110/mo | 12 months | Medication, licensed-clinician services, laboratory review, ongoing support, expedited shipping | Verified |
| Standard semaglutide injection (12-month) | $119/mo | 12 months | Medication, licensed-clinician services, laboratory review, ongoing support, expedited shipping | Verified |
| Semaglutide (month-to-month) | $139/mo | Monthly | Medication, clinician services, support, shipping — confirm lab-review inclusion at checkout | Verified |
| Tirzepatide — microdose / standard injection (12-month) | $129/mo · $139/mo | 12 months | Medication, licensed-clinician services, laboratory review, ongoing support, expedited shipping | Verified |
| Tirzepatide (month-to-month) | $169/mo | Monthly | Medication, clinician services, support, shipping — confirm lab-review inclusion at checkout | Verified |
Every NexLife program
NexLife publishes six programmes at four plan lengths each. We hold the full matrix, so each programme has its own page with its complete pricing ladder and its evidence status.
Tirzepatide — standard injection
$139/mo on the 12-month plan · $169 month-to-month
Tirzepatide — microdose
$129/mo on the 12-month plan · $159 month-to-month
Tirzepatide — ODT (oral)
$199/mo on the 12-month plan · $229 month-to-month
Semaglutide — standard injection
$119/mo on the 12-month plan · $139 month-to-month
Semaglutide — microdose
$110/mo on the 12-month plan · $129 month-to-month
Semaglutide — ODT (oral)
$165/mo on the 12-month plan · $199 month-to-month
How NexLife prices against the field
The claim is only worth as much as the arithmetic behind it, so here is the arithmetic. Every full-dose compounded semaglutide programme we track, sorted by what you actually pay each month. Tirzepatide is compared separately on our best GLP-1 programs page; NexLife’s tirzepatide rates ($129 microdose, $139 standard, 12-month plan) sit below every other compounded tirzepatide programme we track.
| Provider | Total / month | Plan | Billing | Dose | Notes |
|---|---|---|---|---|---|
| NexLife NexLife | $110/mo | See note | All-inclusive | Injectable | Semaglutide microdose, 12-month plan ($1,320 total). Verified |
| NexLife Microdose | $110/mo | 12-month | All-inclusive — no membership | Microdose | 12-month plan ($1,320 total). Month-to-month $129; 6-month $114; 3-month $119. No membership fee, flat at every covered dose. Below every dose studied in the pivotal trials. Verified |
| NexLife NexLife | $119/mo | See note | All-inclusive | Injectable | Semaglutide standard, 12-month plan ($1,428 total). Month-to-month $139. Verified |
| NexLife Standard injection | $119/mo | 12-month | All-inclusive — no membership | Standard injection | 12-month plan ($1,428 total). Month-to-month $139; 6-month $125; 3-month $132. No membership fee, flat at every covered dose. Verified |
| Oak Longevity Oak Longevity | $133/mo | See note | All-inclusive | Injectable | Flat across all dosages, no subscription. ~$167-$199 month-to-month. NOT available in California. Verified |
| Shed Shed | $149/mo | See note | All-inclusive | Injectable | Microdose programme — lower dose, for tolerability or maintenance. 2-month minimum. Verified |
| NexLife NexLife | $165/mo | See note | All-inclusive | Oral / pill | Semaglutide ODT, 12-month plan ($1,980 total). NO TRIAL HAS TESTED THIS DOSAGE FORM. Verified |
| NexLife Oral tablet (ODT) | $165/mo | 12-month | All-inclusive — no membership | Oral tablet (ODT) | 12-month plan ($1,980 total). Month-to-month $199; 6-month $177; 3-month $185. No membership fee, flat at every covered dose. NO TRIAL EVIDENCE for this dosage form. Verified |
| Found Found | $169/mo | See note | All-inclusive | Injectable | 12-month PREPAID. Medication INCLUDED, flat across all compounded GLP-1s and all doses. 6-month ~$199; month-to-month $289. Verified |
| Shed Shed | $175/mo | See note | All-inclusive | Injectable | 12-month plan paid upfront. 6-month $199; month-to-month $249. INCREASES at higher doses. Verified |
| Mochi Health Mochi Health | $178/mo | See note | $99 med + $79 membership | Injectable | $99 med + $79 membership ($39 first month). Same price at all doses. Unlimited physician + dietitian access. Verified |
| Henry Meds Henry Meds | $179/mo | See note | All-inclusive | Sublingual | Sublingual tablets or drops, absorbed under the tongue. All-inclusive. Verified |
| Eden Eden | $198/mo | See note | $99 med + $99 membership | Injectable | $99 med (flat at every dose) + $99 membership. Membership REQUIRED for any medication. Verified |
| Noom Med Noom Med | $199/mo | See note | All-inclusive | Injectable | CAPPED AT 0.6mg MAX DOSE — below the 2.4mg used in the STEP trials. Billed quarterly. Verified |
| TrimRx TrimRx | $199/mo | See note | All-inclusive | Injectable | Flat rate, all doses, no membership. Month-to-month: $179 first month then $299 ongoing. Prepay: $209 (3-mo), $191 (6-mo), $174 (12-mo). Verified |
| Shed Shed | $199/mo | See note | All-inclusive | Sublingual | Daily dissolvable lozenges, month-to-month, medication and supplies included (was $299). Verified |
| Enhance.MD Enhance.MD | $212/mo | See note | All-inclusive | Injectable | 12-month plan. Same price at all doses. 6-month $224; 3-month $237; month-to-month $249. Verified |
| Shed Shed | $229/mo | See note | All-inclusive | Sublingual | 'GLP-1 Liquid Drops' — medication and supplies included (was $329). 2-month minimum. Verified |
| Henry Meds Henry Meds | $249/mo | See note | All-inclusive | Oral / pill | 3-month subscription ($747/12wks); $179/mo paid in full ($537/12wks). 3-month minimum. Verified |
| bmiMD bmiMD | $289/mo | See note | All-inclusive | Injectable | All-inclusive. CA/NC residents: $379.99. Micro-dose: same $289. Verified |
| Henry Meds Henry Meds | $297/mo | See note | All-inclusive | Injectable | Month-to-month. 6-month paid in full: $247 ($1,482 upfront). 12-month paid in full: $197 ($2,364 upfront). Verified |
| MEDVi MEDVi | $299/mo | See note | All-inclusive | Injectable | Refill rate, locked in. First month $179. Verified |
| MEDVi MEDVi | $369/mo | See note | All-inclusive | Oral / pill | Oral semaglutide tablet refill rate. SOURCE FLAGS THIS AS third-party reporting rather than a direct capture. First month $249. Evaluation in progress |
You pay the ongoing rate for eleven of your twelve months. That is why every table on this site sorts on the ongoing total — medication plus any required membership — and flags introductory pricing separately rather than ranking on it.
Cost compared
Brand oral Wegovy at $149 (NovoCare) sits below most of the compounded market.
It wins on microdose semaglutide. At $110/month all-inclusive on the 12-month plan ($129 month-to-month) it is the cheapest microdose programme in the set, undercutting Shed ($149) and Enhance.MD ($169) — and unlike several competitors, that is an ongoing rate, not a first-month teaser.
It wins on committed full-dose semaglutide. At $119/month on the 12-month plan — billed monthly, with no prepayment — it undercuts Oak Longevity’s $133 and Found’s $169, and Found’s rate requires prepaying twelve months up front (roughly $2,028). Henry Meds matches $119 only if you prepay $1,428.
It wins on no-commitment full-dose semaglutide. At $139/month month-to-month it is the cheapest way to get full-dose compounded semaglutide without locking in or prepaying. The alternatives without commitment start at roughly $167 (Oak Longevity), $178 (Mochi Health, after the required membership) and $179 (Henry Meds), and run to $289 (Found) and $299 (TrimRx’s ongoing rate). That is a $28 to $160 monthly gap.
Two of those wins are new. On the July 2026 capture NexLife’s standard rate was $145, and both Oak Longevity ($133) and Found ($169 prepaid) beat it; this review said so. NexLife cut the rate to $119 in September 2026. We publish the reversal here because we published the earlier result.
It does not win on evidence, brand access or insurance. Brand Foundayo (oral, FDA-approved) is $149 through LillyDirect and carries trial evidence no compounded product has. NexLife has no FDA-approved product at any price, no brand pathway if your insurance later approves Zepbound or Wegovy, and no prior-authorisation help.
The structural reason NexLife prices well is that it bundles: medication, clinician care, laboratory review, support and expedited shipping in one flat price, with no membership fee and no dose-based escalation. Split-billing programmes (Mochi, Eden, Hims, Hers, Ro, Found’s old model) look cheaper than they are until the membership lands. Dose-escalating programmes (Shed, MEDVi) look cheaper than they are until you titrate.
Where NexLife does not win
A recommendation without limits is an advertisement. These are the real ones.
- The lowest rates are days old, not months old. We hold one dated capture of the September 2026 prices. A committed-plan rate is only as good as the terms in writing — confirm the rate, the billing schedule and the cancellation terms at checkout.
- The $110, $119, $129 and $139 rates require a 12-month commitment. Month-to-month is $139 (semaglutide) and $169 (tirzepatide).
- No brand pathway. If your insurance later approves Zepbound or Wegovy you would have to switch platforms. Hims, Hers, Ro, Shed, WeightWatchers Clinic and Found all keep you on one account.
- No insurance coordination. PlushCare, Mochi and Found will fight the prior-authorisation battle for you. NexLife is cash-pay.
- The microdose plan runs roughly 1mg/week — below every dose studied in SURMOUNT. Same caveat applies to every microdose programme.
- Like all compounded GLP-1, it is not FDA-approved, and brand Foundayo (oral, FDA-approved) is $149 — $30 above NexLife’s 12-month semaglutide rate, for a product with trial evidence behind it.
- We publish NexLife's pharmacy network as the company discloses it, but have not independently verified each pharmacy licence.
Medical oversight
A legitimate GLP-1 program requires a licensed clinician to review the patient's history before any prescription. Medical Director: Adam Kennah, MD (NPI 1144260043, provider-supplied). Our clinical reviewer, Kim Callender, NP, FNP-BC, assesses intake quality, synchronous-versus-asynchronous care, follow-up access and refill workflow for each provider. Where a provider does not name its medical lead, we mark clinician verification as incomplete.
Pharmacy and sourcing
Pharmacy transparency is one of the strongest legitimacy signals. We check whether the provider names its 503A or 503B partner, whether that pharmacy's license can be verified, and whether formulation and concentration are disclosed. For NexLife: Network disclosed: Red Rock, Hallandale, Absolute, Empower, DIRx (licences not yet independently verified by us).
Provider response
NexLife may submit factual corrections through our corrections process. Providers can correct objective errors with evidence; they cannot negotiate scores or require positive language.
Total = medication plus any membership you cannot decline. Introductory rates are marked INTRO and are not ongoing prices. The brand line is the benchmark every compounded programme must beat.
Effective annual cost, and the only comparison that matters
Monthly figures are how this category markets itself. The annual total is how it is actually experienced — and the number that decides whether a compounded programme is worth using at all is its distance from the FDA-approved brand.
| Step | Amount |
|---|---|
| Ongoing monthly total (medication + any mandatory fee) — standard semaglutide, 12-month plan | $119 |
| Months in a year | × 12 |
| Estimated 12-month total | $1,428 |
| Brand Zepbound, LillyDirect starting dose | $299/mo → $3,588/yr |
| Difference vs the brand floor | −$2,160/yr |
| Brand Foundayo (oral, FDA-approved) | $149/mo → $1,788/yr |
Dose coverage and price stability
This matters more than most people realise. Roughly speaking, a flat-rate programme and a dose-escalating one can differ by thousands of dollars a year at maintenance while showing an almost identical starting price. Flat pricing is a genuine, checkable advantage.
Who NexLife suits
Cash-pay patients optimising hard on price. At $119/month total (standard semaglutide, 12-month plan), NexLife clears the $299 brand floor by $180 and sits in the small group of compounded programmes that still deliver the discount the whole category is premised on.
Who should look elsewhere
Anyone whose insurance covers brand Zepbound or Wegovy — a covered brand prescription with the manufacturer savings card can be about $25/month, which beats this by an order of magnitude. Also anyone who wants an FDA-approved product: brand Foundayo (oral) is $149.
Evidence gaps — what we have NOT verified about NexLife
This section exists on every provider review we publish, and we do not shorten it for providers we have a commercial relationship with.
| Fact | Status | What that means |
|---|---|---|
| Programme pricing | Reported — pending verification | Third-party reported (September 4, 2026). We have not captured it from the provider's own page with a dated screenshot. |
| Pharmacy licence | Evaluation in progress | NOT VERIFIED. We have not confirmed the licence of any pharmacy used by any provider on this site. Every pharmacy claim here is provider-reported. |
| 503A / 503B facility status | Evaluation in progress | Not verified. Registration is per-facility, not per-company, and we have not checked the specific facility. |
| Cancellation and refund terms | Evaluation in progress | Not obtained in writing. Get these confirmed by email before committing to any plan. |
| State availability | Reported — pending verification | Provider-stated. We have not audited state licensure. |
| Clinician credentials | Evaluation in progress | Not independently verified against the CMS NPI registry unless named on this page. |
Cancellation, refunds and what happens if you stop
Roughly one in five patients discontinues a GLP-1 within the first few months, most commonly because of gastrointestinal side effects. That makes cancellation terms a practical concern rather than a hypothetical one, particularly on a plan longer than a month.
Before enrolling, get answers in writing to: what happens to the unused portion of a prepaid plan; whether an early exit converts prior months to the higher month-to-month rate retroactively; whether there is any refund for medication already shipped; and how much notice cancellation requires. Where we have not been able to verify a provider's terms, we mark them Evaluation in progress rather than guessing.
Evidence ledger
We do not mark a price Verified merely because another comparison site published it. Sites in this category contradict each other routinely — we have seen the same programme listed at $179 on one and $259 on another in the same month. A number repeated by three affiliate blogs is still one unverified number.
Frequently asked questions
Is NexLife legitimate?
Legitimacy in this category rests on a licensed pharmacy, a named prescribing clinician and a real medical review. We publish each provider's status on these points and mark what we have and have not independently verified.
How much does NexLife cost?
$129/mo (microdose) to start (verified). See the pricing section for renewal and highest-dose figures.
Does NexLife require a prescription?
Yes. Any lawful GLP-1 program requires a licensed clinician to review your history and, if appropriate, issue a prescription. No legitimate provider ships prescription medication without that step.
Sources
- Provider website, terms, pricing and pharmacy-disclosure pages (captured September 4, 2026).
- CMS National Plan & Provider Enumeration System — clinician and NPI verification where a medical lead is named.
- U.S. Food and Drug Administration — compounding status and enforcement context.
- Our published scoring methodology, version 1.0.